Stay updated on ACTT: Remdesivir for Severe COVID-19 Clinical Trial

Sign up to get notified when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T14:36:47.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error for the study record, with HTML indicating a 403 message and a link back to Home. This indicates the study record is currently inaccessible on ClinicalTrials.gov.
    Difference
    21%
    Check dated 2026-09-23T19:20:54.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A new Revision: v3.7.0 has been added and Revision: v3.6.6 has been removed, indicating an update to the ACTT study's documentation on the page. This update reflects revised protocol details and associated study documentation.
    Difference
    0.0%
    Check dated 2026-09-16T22:02:57.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page revision label updated from v3.6.5 to v3.6.6, indicating a new deployment of the study details page. This likely reflects minor fixes or updates to the page rendering or metadata without altering the study information presented to users.
    Difference
    0.0%
    Check dated 2026-09-02T19:15:59.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, signaling a minor update to the documentation or UI without substantive changes to the study information.
    Difference
    0.0%
    Check dated 2026-08-12T14:32:44.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Revision label in the Study Documents area was updated from v3.6.3 to v3.6.4, indicating a newer version of the protocol document is now referenced.
    Difference
    0.0%
    Check dated 2026-07-21T23:03:40.000Z thumbnail image

Stay in the know with updates to ACTT: Remdesivir for Severe COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.